| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.1B | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS (Basic) | $3.72 | $3.47 | $3.53 | $3.85 | $3.96 | $2.17 | $3.02 | $2.57 |
| EPS (Diluted) | $3.70 | $3.46 | $3.52 | $1.09 | $0.94 | $0.79 | $0.75 | $0.76 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.8B | $9.7B | $9.9B | $9.9B | $8.6B | $7.6B | $6.5B | $6.4B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.2B | $0.1B | $0.1B | $0.1B | $0.8B | $0.7B | $0.3B | $0.2B |
| Total Liabilities | $8.5B | $8.5B | $8.8B | $8.9B | $7.6B | $6.7B | $5.6B | $5.5B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.3B | $1.2B | $1.2B | $1.0B | $1.0B | $0.9B | $0.9B | $0.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.1B | $0.1B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $-0.1B | $0.3B | $0.0B | $-0.7B | $-0.9B | $-0.8B | $-0.0B | $-0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.0B | $-0.3B | $-0.2B | $-0.1B | $0.9B | $1.1B | $-0.0B | $0.1B |